Full Press Release Details
Announcement Summary
ALTERITY THERAPEUTICS LIMITED
Date of this announcement
The Proposed issue is:
A placement or other type of issue
Total number of +securities proposed to be issued
for a placement or other type of issue
| ASX +security code | +Security description | Maximum Number of +securities to be issued | |||
| New class-code to be confirmed | Options with expiry date five (5) years after date of issue and exercise price of A$0.02. | 150,000,000 |
Proposed +issue date
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
| 1.1 Name of +Entity | |
| ALTERITY THERAPEUTICS LIMITED | |
| We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules. If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation). |
| 1.2 Registered Number Type | Registration Number | ||
| ABN | 37080699065 |
| 1.3 ASX issuer code | |
| ATH | |
| 1.4 The announcement is | |
| New announcement | |
| 1.5 Date of this announcement | |
| 19/3/2026 | |
| 1.6 The Proposed issue is: | |
| A placement or other type of issue |
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 Do any external approvals need to be obtained or other conditions satisfied before the
placement or other type of issue can proceed on an unconditional basis?
| Approval/Condition | Date for determination | Is the date estimated or actual? | ** Approval received/condition met? | |
| +Security holder approval | 27/5/2026 | Estimated |
Part 7B - Issue details
Details of +securities proposed to be issued
ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them)
| ASX +security code | +Security description | ||
| New class-code to be confirmed | Options with expiry date five (5) years after date of issue and exercise price of A$0.02. |
Number of +securities proposed to be issued
Are the +securities proposed to be issued being issued for a cash consideration?
Please describe the consideration being provided for the +securities
Please provide an estimate of the AUD equivalent of the consideration being provided for the
Will all the +securities issued in this class rank equally in all respects from their issue
| +Security currency | Exercise price | Expiry date | ||
| AUD - Australian Dollar | AUD 0.0200 | 26/6/2031 |
Details of the type of +security that will be issued if the option is exercised
ATH : ORDINARY FULLY PAID
Number of securities that will be issued if the option is exercised
One fully paid ordinary share (ASX:ATH)
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities
proposed to be issued or provide the information by separate announcement.
To be provided in the future Notice of Meeting announcement.
7C.1 Proposed +issue date 2
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security
holder approval for the entire issue under listing rule 7.1?
7D.1a Date of meeting or proposed meeting to approve
the issue under listing rule 7.1
7D.2 Is a party referred to in listing rule 10.11 participating
in the proposed issue?
7D.3 Will any of the +securities to be issued be +restricted
securities for the purposes of the listing rules?
7D.4 Will any of the +securities to be issued be subject
to +voluntary escrow?
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the
7E.2 Is the proposed issue to be underwritten?
7E.4 Details of any other material fees or costs to be incurred by the entity in connection
with the proposed issue
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
Payment for services rendered for Lawrence Gozlan
and Julian Babarczy.
7F.1 Will the entity be changing its dividend/distribution
policy if the proposed issue proceeds?
7F.2 Any other information the entity wishes to provide about the proposed issue